Trial
NCT01379274
A Trial of Lenalidomide & Azacitidine in Low Risk Myelodysplastic Syndromes
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Rush University Medical Center
Collaborators
Celgene Corporation
Condition
MDS
Intervention
Lenalidomide and azacitidine combination
Why stopped
Loss of funding.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-11-19